Skip to main content
Top
Published in: Cancer Cell International 1/2021

Open Access 01-12-2021 | Retraction Note

Retraction Note to: The lncRNA XIST promotes colorectal cancer cell growth through regulating the miR-497-5p/FOXK1 axis

Authors: Nan Wang, Jia‑Xing He, Guo‑Zhan Jia, Ke Wang, Shuai Zhou, Tao Wu, Xian‑Li He

Published in: Cancer Cell International | Issue 1/2021

Login to get access

Excerpt

The Editors-in-Chief have retracted this article. Concerns were raised regarding Figure 2, specifically:
  • Figure 2c: part of the top right panel appears to be partly covered by a white circle.
  • Figure 2d: the si-NC panels appear to partially overlap.
  • Figure 2e: the si-XIST HT29 panel appear to partially overlap with the siXIST HT29 panel and the si-XIST SW480 panel of Figure 2d.
Metadata
Title
Retraction Note to: The lncRNA XIST promotes colorectal cancer cell growth through regulating the miR-497-5p/FOXK1 axis
Authors
Nan Wang
Jia‑Xing He
Guo‑Zhan Jia
Ke Wang
Shuai Zhou
Tao Wu
Xian‑Li He
Publication date
01-12-2021
Publisher
BioMed Central
Published in
Cancer Cell International / Issue 1/2021
Electronic ISSN: 1475-2867
DOI
https://doi.org/10.1186/s12935-021-02205-2

Other articles of this Issue 1/2021

Cancer Cell International 1/2021 Go to the issue
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine